These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
292 related items for PubMed ID: 7614073
1. The sensitivity of leukemic bone marrow to simvastatin is lost at remission: a potential purging agent for autologous bone marrow transplantation. Newman A, Clutterbuck RD, DeLord C, Powles RL, Catovsky D, Millar JL. J Investig Med; 1995 Jun; 43(3):269-74. PubMed ID: 7614073 [Abstract] [Full Text] [Related]
3. Bone marrow-resident memory T cells survive pretransplant chemotherapy and contribute to early immune reconstitution of patients with acute myeloid leukemia given mafosfamide-purged autologous bone marrow transplantation. Casorati G, Locatelli F, Pagani S, Garavaglia C, Montini E, Lisini D, Turin I, Rossi F, Dellabona P, Maccario R, Montagna D. Exp Hematol; 2005 Feb; 33(2):212-8. PubMed ID: 15676215 [Abstract] [Full Text] [Related]
4. Predictive value of colony-forming unit assays for engraftment and leukemia-free survival after transplantation of chemopurged syngeneic bone marrow in rats. Wiley JM, Yeager AM. Exp Hematol; 1991 Mar; 19(3):179-84. PubMed ID: 1704843 [Abstract] [Full Text] [Related]
5. Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study. Lemoli RM, Visani G, Leopardi G, Motta MR, Rizzi S, Testoni N, Curti A, Tura S. Bone Marrow Transplant; 1999 Feb; 23(3):235-41. PubMed ID: 10084254 [Abstract] [Full Text] [Related]
12. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia. Betticher DC, Huxol H, Müller R, Speck B, Nissen C. Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233 [Abstract] [Full Text] [Related]
13. [Autologous bone marrow transplantation for patients with chronic myelogenous leukemia after in vitro purging of the graft with bcr/abl antisense oligodeoxynucleotides]. Sun J, Wu B, Liu Q, Feng R, Liu X, Meng F, Zhou S. Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):400-2. PubMed ID: 11877009 [Abstract] [Full Text] [Related]
14. [Use of photodynamic therapy for elimination of residual leukemic cells in autologous transplants of hematopoietic progenitor cells]. Hrkal Z, Grebenová D, Cajthamlová H, Soucek J, Bartosová J, Fuchs O, Marinov I, Kobylka P, Klamová H, Sponerová D. Cas Lek Cesk; 2002 Sep 22; 141 Suppl():41-6. PubMed ID: 12428422 [Abstract] [Full Text] [Related]
15. Selective inhibition of primary acute myeloid leukaemia cell growth by lovastatin. Newman A, Clutterbuck RD, Powles RL, Millar JL. Leukemia; 1994 Feb 22; 8(2):274-80. PubMed ID: 8309251 [Abstract] [Full Text] [Related]
16. Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes. Faber LM, van der Hoeven J, Goulmy E, Hooftman-den Otter AL, van Luxemburg-Heijs SA, Willemze R, Falkenburg JH. J Clin Invest; 1995 Aug 22; 96(2):877-83. PubMed ID: 7635982 [Abstract] [Full Text] [Related]
20. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes. Ries C, Loher F, Zang C, Ismair MG, Petrides PE. Clin Cancer Res; 1999 May 22; 5(5):1115-24. PubMed ID: 10353746 [Abstract] [Full Text] [Related] Page: [Next] [New Search]